Brian M. Hahn
2014
In 2014, Brian M. Hahn earned a total compensation of $590.7K as Chief Financial Officer at GlycoMimetics, a 127% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $75,075 |
|---|---|
| Option Awards | $230,267 |
| Salary | $285,387 |
| Total | $590,729 |
Hahn received $285.4K in salary, accounting for 48% of the total pay in 2014.
Hahn also received $75.1K in non-equity incentive plan and $230.3K in option awards.
Rankings
In 2014, Brian M. Hahn's compensation ranked 9,719th out of 13,032 executives tracked by ExecPay. In other words, Hahn earned more than 25.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,719 out of 13,032 | 25th |
Division Manufacturing | 3,675 out of 4,966 | 26th |
Major group Chemicals And Allied Products | 1,252 out of 1,686 | 26th |
Industry group Drugs | 994 out of 1,365 | 27th |
Industry Pharmaceutical Preparations | 763 out of 1,043 | 27th |
Source: SEC filing on April 11, 2016.
Hahn's colleagues
We found three more compensation records of executives who worked with Brian M. Hahn at GlycoMimetics in 2014.
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019